Identification of lysosomal sialidase NEU1 and plasma membrane sialidase NEU3 in human erythrocytes1. Issue 1 (14th November 2012)

• Record Type: Journal Article
• Authors: D'Avila, Francesca; Tringali, Cristina; Papini, Nadia; Anastasia, Luigi; Croci, Gianluigi; Massaccesi, Luca; Monti, Eugenio; Tettamanti, Guido; Venerando, Bruno
• Is Part Of: Journal of cellular biochemistry. Volume 114:Issue 1(2013:Jan.)
• Page Start: 204
• Page End: 211
• Publication Date: 2012-11-14
• Subjects: Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.24355
• Languages: English
• ISSNs: 0730-2312

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>The sialylation level of molecules, sialoglycoproteins and gangliosides, protruding from plasma membranes regulates multiple facets of erythrocyte function, from interaction with endothelium to cell lifespan. Our results demonstrate that: (a) Both sialidases NEU1 and NEU3 are present on erythrocyte plasma membrane; (b) NEU1 is kept on the plasma membrane in absence of the protective protein/cathepsin A (PPCA); (c) NEU1 and NEU3 are retained on the plasma membrane, as peripheral proteins, associated to the external leaflet and released by alkaline treatments; (d) NEU1 and NEU3 are segregated in Triton X‐100 detergent‐resistant membrane domains (DRMs); (e) NEU3 shows activity also at neutral pH; and (f) NEU1 and NEU3 are progressively lost during erythrocyte life. Interestingly, sialidase activity released from erythrocyte membranes after an alkaline treatment preserves its functionality and recognizes sialoglycoproteins and gangliosides. On the other hand, the weak anchorage of sialidases to the plasma membrane and their loss during erythrocyte life could be a tool to preserve the cellular sialic acid content in order to avoid the early ageing of erythrocyte and processes of cell aggregation in the capillaries. J. Cell. Biochem. 114: 204–211, 2012. © 2012 Wiley Periodicals, Inc.</p> </abstract>